A carregar...
Pimavanserin: A Novel Drug Approved to Treat Parkinson’s Disease Psychosis
Objective: Pimavanserin is the first United States Food and Drug Administration (FDA)-approved treatment for Parkinson’s disease psychosis (PDP). This article reviews the safety, efficacy, and pharmacology data for pimavanserin and its role in therapy. Method of Research: Initial literature sources...
Na minha lista:
| Publicado no: | Innov Clin Neurosci |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Matrix Medical Communications
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5819716/ https://ncbi.nlm.nih.gov/pubmed/29497575 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|